Roche CEO: In economic crisis, innovators thrive

As far as Roche CEO Severin Schwan (photo) is concerned, the European economic crisis will trigger deep cuts in healthcare spending, leaving room for only two types of Big Pharma players: Generic drugmakers with the economies of scale needed to market huge volumes of cheap drugs and innovators that can conjure a new generation of therapies that offer markedly better outcomes for patients. Report